Please provide your email address to receive an email when new articles are posted on . “Although rare, the effect of a painful, spontaneous atypical femur fracture is devastating,” Hanh H. Nguyen, ...

Please provide your email address to receive an email when new articles are posted on . The reduced risks for osteoporotic and hip fractures with bisphosphonate therapy outweigh increased risk for ...

(HealthDay News) — Bisphosphonate use, especially over a long duration, is associated with increased risk of atypical femoral fracture, according to a study published in the September 4 issue of the ...

Mortality risk did not differ significantly after AFF vs after hip or ST/FS fractures among men receiving bisphosphonates for fracture prevention.

The relative risk of an atypical femoral fracture with bisphosphonate use related to duration of therapy, with the highest risks being seen after 5 years of exposure, a nationwide study in Denmark ...

AP X-ray of an 82 year old female with bisphosphonate related atypical transverse stress insufficiency fracture associated with focal lateral cortical thickening of subtrochanteric cortex of proximal ...

A major UK-based study has found that denosumab, a widely used osteoporosis medication, does not raise the risk of atypical femur fractures compared with bisphosphonates over four years. The result ...

A team of researchers of the University of Barcelona and the Hospital del Mar Medical Research Institute (IMIM) have discovered a new mutation that has an impact on the bone so that it is vulnerable ...

The risk of atypical femur fractures increases with prolonged use of bisphosphonates, drugs commonly used to treat osteoporosis, according to a new study. The research, conducted by scientists at the ...

The FDA has notified healthcare professionals and patients that at this point, the data that have been reviewed have not shown a clear connection between bisphosphonate use and a risk of atypical ...

Bisphosphonate use is associated with only a very low risk of atypical fractures to the subtrochanteric or diaphyseal femur, even in women who receive the drugs for up to 10 years, data from an ...